Keywords: cytos, sees, sales, rocket, 1st-qtr, switzerland, biotechnology
Cytos sees sales rocket 870% for 1st-qtr
Article | 03 May 2004
Switzerland's Cytos Biotechnology AG has posted an enormous 870% leap in revenues to 2.7 million Swiss francs ($2.1 million) for the first quarter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
